Floatz logo

Procarbazine

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

National Cancer Institute (NCI)Small moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

149 Active assets in the Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 3BBB
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BBB
METHOTREXATE
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
CARMUSTINE
VIVUS LLC
Phase 2BBB
Carboplatin
St. Petersburg State Pavlov Medical University
Phase 2BBB

View all 50 →

Same molecule, other indications

Procarbazine is also rated in:

central nervous system neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
lymphomaDormant
BB
Indicative ·
69 / 100
View asset →
Adult Giant Cell GlioblastomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →